Stay updated on Filgotinib and Lanraplenib in Female CLE Clinical Trial

Sign up to get notified when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib and Lanraplenib in Female CLE Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    4%
    Check dated 2025-10-06T16:10:45.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T10:14:24.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' navigation item has been removed. No substantive content changes were detected.
    Difference
    0.2%
    Check dated 2025-09-15T02:41:36.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T23:00:43.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several terms related to diseases and previous location details have been removed.
    Difference
    2%
    Check dated 2025-08-31T19:56:59.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T12:30:53.000Z thumbnail image

Stay in the know with updates to Filgotinib and Lanraplenib in Female CLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.